Pharmaceutical Industry

Page 13 of 100

Johnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years
Finance

Johnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years

By
May 1, 2024
AMR is on track to lower global life expectancy by an average 1.8 years by 2035, according to a new report from the Global Leaders Group on Antimicrobial Resistance.
Health

Superbugs could lower your life expectancy by nearly 2 years, report says. What to know about antimicrobial resistance

By
April 26, 2024
A scientist in a lab coat peers into a microscope in a lab.
Newsletters

AI for drug discovery draws a $1 billion launch—and a lot of hope

By
April 25, 2024
Bill Anderson, chief executive officer of Bayer
Leadership

Pharmaceutical giant Bayer’s manager cull will likely affect thousands of bosses—and the aspirin inventor thinks it will help its ‘brilliant’ Gen Z grads to thrive

By
April 24, 2024
How Moderna’s CIO helps steer the drugmaker’s post-COVID evolution
Newsletters

How Moderna’s CIO helps steer the drugmaker’s post-COVID evolution

By
April 17, 2024
Bill Anderson, chief executive officer of Bayer
Leadership

Pharmaceutical giant Bayer is getting rid of bosses and asking nearly 100,000 workers to ‘self-organize’ to save $2.15 billion

By
April 11, 2024
Pascal Soriot, chief executive officer of Astrazeneca Plc, arrives at the CEO council at the Great Hall of the People in Beijing, Chin
Success

Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO

By
April 10, 2024
Many cancer drugs remain unproven 5 years after accelerated approval, a study finds
Health

Many cancer drugs remain unproven 5 years after accelerated approval, a study finds

By Carla K. Johnson and The Associated Press
April 8, 2024
ALS drug will be pulled from US market after study showed patients didn’t benefit
Health

ALS drug will be pulled from US market after study showed patients didn’t benefit

By Matthew Perrone and The Associated Press
April 4, 2024
It’s time for facts in the PBM debate
Commentary

It’s time for facts in the PBM debate

By
April 3, 2024
photo portrait of a middle aged man wearing a suit and tie
Newsletters

Johnson & Johnson CIO says employee upskilling is key to transforming health care

By
April 3, 2024
Pharmacies
Health

‘This is an emergency’: Trade group warns nearly a third of all independent pharmacies will go extinct because of a CMS rule

By Maia Anderson, Healthcare Brew and Morning Brew
March 30, 2024
An out-of-focus person is point to their left and is standing in front of a window with the red and white Walgreens 'W' on it.
Retail

Walgreens’ frail quarter goes beyond the discretionary spending dips afflicting its competitors. It’s ‘just not very good at retailing,’ analyst says

By
March 29, 2024
The economics of antibiotics are broken and superbugs are on the rise–but a solution inspired by the subscription economy could save millions of lives
Commentary

The economics of antibiotics are broken and superbugs are on the rise–but a solution inspired by the subscription economy could save millions of lives

By
March 28, 2024
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
Health

Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5

By Madison Muller, Robert Langreth and Bloomberg
March 28, 2024

Most Popular